Uganda - English - National Drug Authority

square pharmaceuticals ltd.pabna unit - oxymetazoline hydrochloride - nasal topical drops - 0.025w/v%

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - oxymetazoline hydrochloride -

Malta - English - Medicines Authority

uriach consumer healthcare sl av. cami reial, 51-57, 08184 palau- solita i plegamans, barcelona, spain - oxymetazoline hydrochloride - nasal spray, solution - oxymetazoline hydrochloride 0.5 mg/ml - nasal preparations

Canada - English - Health Canada

johnson & johnson inc - oxymetazoline hydrochloride - drops - 0.025% - oxymetazoline hydrochloride 0.025% - vasoconstrictors

Ireland - English - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals ireland - oxymetazoline hydrochloride - eye drops solution - 0.025 %w/v

Canada - English - Health Canada

schering-plough canada inc - oxymetazoline hydrochloride - drops - .25mg - oxymetazoline hydrochloride .25mg - vasoconstrictors

United States - English - NLM (National Library of Medicine)

dynamic pharmaceuticals - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.2 mg in 0.4 ml - nasal decongestant temporarily relieves nasal congestion due to: - common cold - hay fever - upper respiratory allergies - helps clear nasal passages - shrinks swollen membranes - temporarily relieves sinus congestion and pressure

United States - English - NLM (National Library of Medicine)

cadila healthcare limited - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.5 mg in 1 ml - nasal decongestant - temporarily relieves nasal congestion due to:                                    ■ a cold ■ hay fever ■ upper respiratory allergies - promotes nasal and sinus drainage - temporarily relieves sinus congestion and pressure - helps clear nasal passages; shrinks swollen membranes

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride 0.5 mg in 1 ml - nasal decongestant - temporarily relieves nasal congestion due to:                                    ■ a cold ■ hay fever ■ upper respiratory allergies - promotes nasal and sinus drainage - temporarily relieves sinus congestion and pressure - helps clear nasal passages; shrinks swollen membranes

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - oxymetazoline hydrochloride cream is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. none. risk summary there are no available data on oxymetazoline hydrochloride use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. a literature article describing intranasal decongestant use in pregnant women identified a potential association between second-trimester exposure to oxymetazoline (with no decongestant exposure in the first trimester) and renal collecting system anomalies [see data] . in animal reproduction studies, there were no adverse developmental effects observed after oral administration of oxymetazoline hydrochloride in pregnant rats and rabbits at systemic exposures up to 3 times and 73 times, respectively, the exposure associated with the maximum recommended human dose (mrhd) [see data] . the estimated background risks of major birth defects and miscarriage for the indicated population are unknown. all pregnan